Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein 57 like 1 (CEP57L1) is a centrosome-associated protein involved in the maintenance of centriole engagement and proper centrosome duplication during the cell cycle[2][5][3]. It cooperates with its paralog CEP57 to ensure that centrioles remain properly engaged during interphase, preventing premature centriole disengagement and reduplication[2]. Loss or depletion of CEP57L1, especially in combination with loss of CEP57, results in abnormal centriole disengagement, centriole reduplication, and chromosome segregation errors that can contribute to cell division defects and potentially to genomic instability in cancer[2]. CEP57L1 is predicted to bind identical proteins and gamma-tubulin[3][6], is located at the centrosome, and is required for microtubule attachment to centrosomes, impacting proper organization and tethering of microtubule minus ends[7]. However, it is not regarded as a classic therapeutic target such as a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein 57 like 1 (CEP57L1).